Skip to main content
Top
Published in: BMC Nephrology 1/2017

Open Access 01-12-2017 | Research article

Predictive abilities of cardiovascular biomarkers to rapid decline of renal function in Chinese community-dwelling population: a 5-year prospective analysis

Authors: Shihui Fu, Chunling Liu, Leiming Luo, Ping Ye

Published in: BMC Nephrology | Issue 1/2017

Login to get access

Abstract

Background

Predictive abilities of cardiovascular biomarkers to renal function decline are more significant in Chinese community-dwelling population without glomerular filtration rate (GFR) below 60 ml/min/1.73m2, and long-term prospective study is an optimal choice to explore this problem. Aim of this analysis was to observe this problem during the follow-up of 5 years.

Methods

In a large medical check-up program in Beijing, there were 948 participants with renal function evaluated at baseline and follow-up of 5 years. Physical examinations were performed by well-trained physicians. Blood samples were analyzed by qualified technicians in central laboratory.

Results

Median rate of renal function decline was 1.46 (0.42–2.91) mL/min/1.73m2/year. Rapid decline of renal function had a prevalence of 23.5% (223 participants). Multivariate linear and Logistic regression analyses confirmed that age, sex, baseline GFR, homocysteine and N-terminal pro B-type natriuretic peptide (NT-proBNP) had independently predictive abilities to renal function decline rate and rapid decline of renal function (p < 0.05 for all). High-sensitivity cardiac troponin T (hs-cTnT), carotid femoral pulse wave velocity and central augmentation index had no statistically independent association with renal function decline rate and rapid decline of renal function (p > 0.05 for all).

Conclusions

Homocysteine and NT-proBNP rather than hs-cTnT had independently predictive abilities to rapid decline of renal function in Chinese community-dwelling population without GFR below 60 ml/min/1.73m2. Baseline GFR was an independent factor predicting the rapid decline of renal function. Arterial stiffness and compliance had no independent effect on rapid decline of renal function. This analysis has a significant implication for public health, and changing the homocysteine and NT-proBNP levels might slow the rapid decline of renal function.
Literature
1.
go back to reference Rein P1, Saely CH, Muendlein A, et al. Serial decline of renal function as a novel biomarker for the progression of atherothrombotic disease. Atherosclerosis. 2010;211:348–52.CrossRefPubMed Rein P1, Saely CH, Muendlein A, et al. Serial decline of renal function as a novel biomarker for the progression of atherothrombotic disease. Atherosclerosis. 2010;211:348–52.CrossRefPubMed
2.
go back to reference Oh J, Wunsch R, Turzer M, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106:100–5.CrossRefPubMed Oh J, Wunsch R, Turzer M, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106:100–5.CrossRefPubMed
3.
go back to reference Henry RM, Kostense PJ, Bos G, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn study. Renal Int. 2002;62:1402–7. Henry RM, Kostense PJ, Bos G, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn study. Renal Int. 2002;62:1402–7.
4.
go back to reference Bostom AG, Kronenberg F, Jacques PF, et al. Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate. Atherosclerosis. 2001;159:219–23.CrossRefPubMed Bostom AG, Kronenberg F, Jacques PF, et al. Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate. Atherosclerosis. 2001;159:219–23.CrossRefPubMed
5.
go back to reference Ducloux D, Motte G, Challier B, et al. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. J Am Soc Nephrol. 2000;11:134–7.PubMed Ducloux D, Motte G, Challier B, et al. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. J Am Soc Nephrol. 2000;11:134–7.PubMed
6.
go back to reference Brattstrom L, Wilcken DE. Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr. 2000;72:315–23.PubMed Brattstrom L, Wilcken DE. Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr. 2000;72:315–23.PubMed
7.
go back to reference Ueland PM, Refsum H, Beresford SA, et al. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr. 2000;72:324–32.PubMed Ueland PM, Refsum H, Beresford SA, et al. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr. 2000;72:324–32.PubMed
8.
go back to reference Hiramoto JS, Katz R, Peralta CA, et al. Inflammation and coagulation markers and renal function decline: the multi-ethnic study of atherosclerosis (MESA). Am J renal Dis. 2012;60:225–32. Hiramoto JS, Katz R, Peralta CA, et al. Inflammation and coagulation markers and renal function decline: the multi-ethnic study of atherosclerosis (MESA). Am J renal Dis. 2012;60:225–32.
9.
go back to reference Francis ME, Eggers PW, Hostetter TH, et al. Association between serum homocysteine and markers of impaired renal function in adults in the United States. Renal Int. 2004;66:303–12. Francis ME, Eggers PW, Hostetter TH, et al. Association between serum homocysteine and markers of impaired renal function in adults in the United States. Renal Int. 2004;66:303–12.
10.
go back to reference Peralta CA, Katz R, DeBoer I, et al. Racial and ethnic differences in renal function decline among persons without chronic renal disease. J Am Soc Nephrol. 2011;22:1327–34.CrossRefPubMedPubMedCentral Peralta CA, Katz R, DeBoer I, et al. Racial and ethnic differences in renal function decline among persons without chronic renal disease. J Am Soc Nephrol. 2011;22:1327–34.CrossRefPubMedPubMedCentral
11.
go back to reference Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic renal disease. J Am Soc Nephrol. 2006;17:2937–44.CrossRefPubMed Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic renal disease. J Am Soc Nephrol. 2006;17:2937–44.CrossRefPubMed
13.
go back to reference Eriksen BO, Ingebretsen OC. The progression of chronic renal disease: a 10-year population based study of the effects of gender and age. Renal Int. 2006;69:375–82. Eriksen BO, Ingebretsen OC. The progression of chronic renal disease: a 10-year population based study of the effects of gender and age. Renal Int. 2006;69:375–82.
14.
go back to reference Ruan L, Chen W, Srinivasan SR, et al. Plasma homocysteine is adversely associated with glomerular filtration rate in asymptomatic black and white young adults: the Bogalusa heart study. Eur J Epidemiol. 2009;24:315–9.CrossRefPubMed Ruan L, Chen W, Srinivasan SR, et al. Plasma homocysteine is adversely associated with glomerular filtration rate in asymptomatic black and white young adults: the Bogalusa heart study. Eur J Epidemiol. 2009;24:315–9.CrossRefPubMed
15.
go back to reference Sarnak MJ, Wang SR, Beck GJ, et al. Homocysteine, cysteine, and B vitamins as predictors of renal disease progression. Am J renal Dis. 2002;40:932–9. Sarnak MJ, Wang SR, Beck GJ, et al. Homocysteine, cysteine, and B vitamins as predictors of renal disease progression. Am J renal Dis. 2002;40:932–9.
16.
go back to reference Davi G, Diminno G, Goppola A, et al. Oxidative stress and platelet activation in homozygous homocystinuria. Circulation. 2001;104:1124–8.CrossRefPubMed Davi G, Diminno G, Goppola A, et al. Oxidative stress and platelet activation in homozygous homocystinuria. Circulation. 2001;104:1124–8.CrossRefPubMed
17.
go back to reference Stuhlinger MC, Tsao PS. Her JH, et al. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation. 2001;104:2569–75.CrossRefPubMed Stuhlinger MC, Tsao PS. Her JH, et al. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation. 2001;104:2569–75.CrossRefPubMed
18.
go back to reference Davi G, Diminno G, Coppola A, et al. Oxidative stress and platelet activation in homozygous homocystinuria. Circulation. 2001;104:1124–8.CrossRefPubMed Davi G, Diminno G, Coppola A, et al. Oxidative stress and platelet activation in homozygous homocystinuria. Circulation. 2001;104:1124–8.CrossRefPubMed
19.
go back to reference Tofler GH, D’Agostino RB, Jacques PF, et al. Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk. Thromb Haemost. 2002;88:799–804.PubMed Tofler GH, D’Agostino RB, Jacques PF, et al. Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk. Thromb Haemost. 2002;88:799–804.PubMed
20.
go back to reference Seki N1, Nishimura M, Matsumoto T, et al. Relationship between BNP level and renal function in diabetic nephropathy with microalbuminuria. J Diabetes Complicat. 2013;27:92–7.CrossRef Seki N1, Nishimura M, Matsumoto T, et al. Relationship between BNP level and renal function in diabetic nephropathy with microalbuminuria. J Diabetes Complicat. 2013;27:92–7.CrossRef
21.
go back to reference Spanaus KS, Kronenberg F, Ritz E, et al. Mild-to-Moderate renal Disease Study Group. B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic renal disease: the mild-to-moderate renal disease study. Clin Chem. 2007;53:1264–72.CrossRefPubMed Spanaus KS, Kronenberg F, Ritz E, et al. Mild-to-Moderate renal Disease Study Group. B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic renal disease: the mild-to-moderate renal disease study. Clin Chem. 2007;53:1264–72.CrossRefPubMed
22.
go back to reference Jerums G, Premaratne E, Panagiotopoulos S, et al. The clinical significance of hyperfiltration in diabetes. Diabetologia. 2010;53:2093–104.CrossRefPubMed Jerums G, Premaratne E, Panagiotopoulos S, et al. The clinical significance of hyperfiltration in diabetes. Diabetologia. 2010;53:2093–104.CrossRefPubMed
23.
go back to reference Sakamoto K, Kikkawa R, Haneda M, et al. Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist. Diabetologia. 1995;38:536–42.CrossRefPubMed Sakamoto K, Kikkawa R, Haneda M, et al. Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist. Diabetologia. 1995;38:536–42.CrossRefPubMed
24.
go back to reference Zhang PL, Mackenzie HS, Troy JL, et al. Effects of an atrial natriuretic peptide receptor antagonist on glomerular hyperfiltration in diabetic rats. J Am Soc Nephrol. 1994;4:1564–70.PubMed Zhang PL, Mackenzie HS, Troy JL, et al. Effects of an atrial natriuretic peptide receptor antagonist on glomerular hyperfiltration in diabetic rats. J Am Soc Nephrol. 1994;4:1564–70.PubMed
26.
go back to reference Sesso R1, Prado F, Vicioso B, et al. Prospective study of progression of renal dysfunction in community-dwelling older adults. Nephrology (Carlton). 2008;13:99–103.CrossRef Sesso R1, Prado F, Vicioso B, et al. Prospective study of progression of renal dysfunction in community-dwelling older adults. Nephrology (Carlton). 2008;13:99–103.CrossRef
27.
go back to reference Seki N, Nishimura M, Matsumoto T, et al. Relationship between BNP level and renal function in diabetic nephropathy with microalbuminuria. J Diabetes Complicat. 2013;27:92–7.CrossRefPubMed Seki N, Nishimura M, Matsumoto T, et al. Relationship between BNP level and renal function in diabetic nephropathy with microalbuminuria. J Diabetes Complicat. 2013;27:92–7.CrossRefPubMed
28.
go back to reference Yokoyama H, Kanno S, Takahashi S, et al. Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension. Clin J Am Soc Nephrol. 2009;4:1432–40.CrossRefPubMedPubMedCentral Yokoyama H, Kanno S, Takahashi S, et al. Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension. Clin J Am Soc Nephrol. 2009;4:1432–40.CrossRefPubMedPubMedCentral
29.
go back to reference Moriya T, Tsuchiya A, Okizaki S, et al. Glomerular hyperfiltration and increased glomerular filtration surface are associated with renal function decline in normo- and microalbuminuric type 2 diabetes. Renal International. 2011;81:486–93. Moriya T, Tsuchiya A, Okizaki S, et al. Glomerular hyperfiltration and increased glomerular filtration surface are associated with renal function decline in normo- and microalbuminuric type 2 diabetes. Renal International. 2011;81:486–93.
30.
go back to reference Rifkin DE, Katz R, Chonchol M, et al. Blood pressure components and decline in renal function in community-living older adults: the cardiovascular health study. Am J Hypertens. 2013;26:1037–44.CrossRefPubMedPubMedCentral Rifkin DE, Katz R, Chonchol M, et al. Blood pressure components and decline in renal function in community-living older adults: the cardiovascular health study. Am J Hypertens. 2013;26:1037–44.CrossRefPubMedPubMedCentral
31.
go back to reference Kronborg J1, Solbu M, Njølstad I, et al. Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study. Nephrol Dial Transplant. 2008;23:2818–26.CrossRefPubMed Kronborg J1, Solbu M, Njølstad I, et al. Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study. Nephrol Dial Transplant. 2008;23:2818–26.CrossRefPubMed
32.
go back to reference van Bemmel T, Woittiez K, Blauw GJ, et al. Prospective study of the effect of blood pressure on renal function in old age: the Leiden 85-plus study. J Am Soc Nephrol. 2006;17:2561–6.CrossRefPubMed van Bemmel T, Woittiez K, Blauw GJ, et al. Prospective study of the effect of blood pressure on renal function in old age: the Leiden 85-plus study. J Am Soc Nephrol. 2006;17:2561–6.CrossRefPubMed
33.
go back to reference Ford ML, Tomlinson LA, Chapman TP, et al. Aortic stiffness is independently associated with rate of renal function decline in chronic renal disease stages 3 and 4. Hypertension. 2010;55:1110–5.CrossRefPubMed Ford ML, Tomlinson LA, Chapman TP, et al. Aortic stiffness is independently associated with rate of renal function decline in chronic renal disease stages 3 and 4. Hypertension. 2010;55:1110–5.CrossRefPubMed
34.
go back to reference Elias MF, Davey A, Dore GA, et al. Deterioration in renal function is associated with increased arterial stiffness. Am J Hypertens. 2014;27:207–14.CrossRefPubMed Elias MF, Davey A, Dore GA, et al. Deterioration in renal function is associated with increased arterial stiffness. Am J Hypertens. 2014;27:207–14.CrossRefPubMed
35.
go back to reference Kim CS, Kim HY, Kang YU, et al. Association of pulse wave velocity and pulse pressure with decline in renal function. J Clin Hypertens (Greenwich). 2014;16:372–7.CrossRef Kim CS, Kim HY, Kang YU, et al. Association of pulse wave velocity and pulse pressure with decline in renal function. J Clin Hypertens (Greenwich). 2014;16:372–7.CrossRef
Metadata
Title
Predictive abilities of cardiovascular biomarkers to rapid decline of renal function in Chinese community-dwelling population: a 5-year prospective analysis
Authors
Shihui Fu
Chunling Liu
Leiming Luo
Ping Ye
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2017
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-017-0743-y

Other articles of this Issue 1/2017

BMC Nephrology 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.